Though canine pancreatic neuroendocrine neoplasms (PanNENs) have been proposed as a mannequin for the counterpart human neoplasms, the kind or grade of human PanNEN that they resemble is unclear. PanNENs in animals are categorised as adenoma or carcinoma, whereas in people they’re categorised as pancreatic neuroendocrine tumour (PanNET) if well-differentiated, or as pancreatic neuroendocrine carcinoma (PanNEC) if poorly differentiated.
We evaluated 16 canine main PanNENs and two metastases histologically and immunohistochemically, and graded them utilizing the animal and human grading techniques. All neoplasms had native or vascular invasion and had been categorised as pancreatic islet cell carcinomas in accordance with the present WHO classification. The Ki-67 index was low in all instances (0.01-1.50%). All had cytoplasmic expression of synaptophysin and insulin however had been immunonegative for glucagon, confirming a purposeful analysis of canine insulinoma. Membranous expression of SSTR2A and nuclear expression of ATRX, however no p53 expression, was present in all neoplasms.
One main tumour was recognized as a combined neuroendocrine-non-neuroendocrine neoplasm, which is the primary report of this neoplasm in canines. The opposite 15 main tumours and each metastatic tumours had been graded as PanNET G1, in accordance with the human WHO classification. We conclude that canine PanNENs share well-differentiated histomorphology, SSTR2A expression and absence of nuclear p53 immunolabelling with human PanNETs G1. Nevertheless, they differ in ATRX gene expression and performance, and appear to have a worse prognosis than human PanNETs G1, though their typically low Ki-67 index precludes extra exact evaluation of prognosis. Membranous SSTR2A expression renders canine PanNENs doubtlessly amenable to remedy with somatostatin analogues or SSTR focused in-vivo imaging strategies.
Gene Augmentation and Enhancing to Enhance TCR Engineered T Cell Remedy in opposition to Stable Tumors
Latest developments in gene engineering applied sciences have drastically improved the therapeutic remedy choices for most cancers sufferers. The usage of efficient chimeric antigen receptor T (CAR-T) cells and recombinant T cell receptor engineered T (rTCR-T) cells has entered the clinic for remedy of hematological malignancies with promising outcomes. Nevertheless, additional fine-tuning, to enhance performance and security, is important to use these methods for the remedy of strong tumors. The immunosuppressive microenvironment, the encompassing stroma, and the tumor heterogeneity usually leads to poor T cell reactivity, performance, and a diminished infiltration charges, hampering the efficacy of the remedy.
The main focus of this assessment is on current advances in rTCR-T cell remedy, to enhance each performance and security, for potential remedy of strong tumors and offers an summary of ongoing scientific trials. In addition to collection of the suitable tumor related antigen, environment friendly supply of an optimized recombinant TCR transgene into the T cells, together with gene modifying methods eliminating the endogenous TCR expression and disrupting particular inhibitory pathways may enhance adoptively transferred T cells. Armoring the rTCR-T cells with particular cytokines and/or chemokines and their receptors, or concentrating on the tumor stroma, can improve the infiltration price of the immune cells inside the strong tumors.
Alternatively, scientific “off-tumor/on-target” toxicities are nonetheless a significant potential threat and might result in extreme antagonistic occasions. Incorporation of security switches in rTCR-T cells can assure further security. Latest scientific trials present encouraging knowledge and emphasize the relevance of gene remedy and gene modifying instruments for potential remedy of strong tumors.

Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation
Lengthy-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric most cancers-mimicking superior gastric most cancers: Propensity rating matching evaluation
Laparoscopic gastrectomy grew to become an choice within the remedy of early gastric most cancers (EGC) in scientific observe. Nevertheless, whether or not laparoscopic surgical procedure for grossly EGC-mimicking superior gastric most cancers (AGC) sufferers is oncologically secure long-term remains to be controversial.We retrospectively analyzed 472 sufferers with AGC who had been recognized as scientific EGC. Sufferers acquired laparoscopic or open gastrectomy with customary lymph node (LN) dissection from January 2007 to February 2015. We used a 1:Three propensity rating matching technique for the evaluation. The matching elements had been age, intercourse, physique mass index, American Society of Anesthesiologists rating and pathologic stage.
After the matching course of, we evaluated the 5-year general survival and the cumulative incidence curve of recurrence.The entire analyzed sufferers had been pathologically recognized with AGC after surgical procedure (grossly EGC-mimicking AGC). The median (vary) period of follow-up was 58.0 (0-132) months. After propensity rating matching, 31.5% of sufferers within the laparoscopy group had D1+ LN dissection and 99.2% of sufferers within the open group had D2 LN dissection. The 5-year general survival price between the laparoscopy (n = 92) and open teams (n = 244) weren’t considerably totally different.
Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E06O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E06O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E06O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E08O0338-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E08O0338-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E08O0338-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E03O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E03O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E03O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E04O0334--192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E04O0334--48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E04O0334--96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E07O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E07O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E07O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E02O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E02O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E02O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E09O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E09O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E09O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E05O0334-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E05O0334-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit |
E05O0334-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody |
20-abx173927 |
Abbexa |
|
|
|
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody |
20-abx129287 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1579.20
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Antibody |
20-abx339623 |
Abbexa |
|
|
|
Recombinant Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) |
4-RPR870Hu01 |
Cloud-Clone |
-
EUR 603.84
-
EUR 285.60
-
EUR 1934.40
-
EUR 724.80
-
EUR 1329.60
-
EUR 480.00
-
EUR 4656.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 expressed in: E.coli |
Cancer Antigen 242 Antigen |
VAng-Cr3876-10kU |
Creative Biolabs |
10 kU |
EUR 505.2 |
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration. |
Cancer Antigen 50 Antigen |
VAng-Cr3877-50kU |
Creative Biolabs |
50 kU |
EUR 6642 |
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Human Cancer PrimaCell12: Ovarian Tumor Cells |
2-96035 |
CHI Scientific |
1 Kit |
Ask for price |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Protein |
20-abx167980 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2598.00
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Cancer Antigen 72-4 Antigen |
VAng-Cr3878-10kU |
Creative Biolabs |
10 kU |
EUR 505.2 |
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Mouse ovarian cancer marker-CA125 ELISA Kit |
CN-02753M1 |
ChemNorm |
96T |
EUR 580.8 |
Mouse ovarian cancer marker-CA125 ELISA Kit |
CN-02753M2 |
ChemNorm |
48T |
EUR 402 |
Human Ovarian cancer marker-CA125 ELISA Kit |
EHO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Porcine Ovarian cancer marker-CA125 ELISA Kit |
EPO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse Ovarian cancer marker-CA125 ELISA Kit |
EMO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Rat Ovarian cancer marker-CA125 ELISA Kit |
ERO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit Ovarian cancer marker-CA125 ELISA Kit |
ERTO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Human ovarian cancer marker-CA125 ELISA Kit |
201-12-1663 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human ovarian cancer antigenX1,OVX1 ELISA Kit |
201-12-2137 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Goat Ovarian cancer marker-CA125 ELISA Kit |
EGTO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Anserini Ovarian cancer marker-CA125 ELISA Kit |
EAO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Bovine Ovarian cancer marker-CA125 ELISA Kit |
EBO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Human ovarian cancer marker-CA125 ELISA Kit |
GA-E1679HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human ovarian cancer marker-CA125 ELISA Kit |
GA-E1679HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Rat ovarian cancer marker-CA125 ELISA Kit |
GA-E0455RT-48T |
GenAsia Biotech |
48T |
EUR 380.4 |
Rat ovarian cancer marker-CA125 ELISA Kit |
GA-E0455RT-96T |
GenAsia Biotech |
96T |
EUR 595.2 |
Mouse ovarian cancer marker-CA125 ELISA Kit |
GA-E0540MS-48T |
GenAsia Biotech |
48T |
EUR 403.2 |
Mouse ovarian cancer marker-CA125 ELISA Kit |
GA-E0540MS-96T |
GenAsia Biotech |
96T |
EUR 640.8 |
Canine Ovarian cancer marker-CA125 ELISA Kit |
ECO0345 |
Abclonal |
96Tests |
EUR 625.2 |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
DLR-OCIAD2-Hu-48T |
DL Develop |
48T |
EUR 664.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from tissue homogenates, cell lysates or other biological fluids. |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
DLR-OCIAD2-Hu-96T |
DL Develop |
96T |
EUR 870 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from tissue homogenates, cell lysates or other biological fluids. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human) |
4-PAR870Hu01 |
Cloud-Clone |
-
EUR 314.40
-
EUR 3296.40
-
EUR 814.80
-
EUR 397.20
-
EUR 264.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
RD-OCIAD2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 675.6 |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
RD-OCIAD2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 939.6 |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
RDR-OCIAD2-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 706.8 |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
RDR-OCIAD2-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 984 |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
SER870Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 6227.58 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids. |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
SER870Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 618.04 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids. |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
SER870Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 831.48 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids. |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
SER870Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3381.66 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in Tissue homogenates, cell lysates and other biological fluids. |
Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ELISA Kit |
4-SER870Hu |
Cloud-Clone |
-
EUR 6288.00
-
EUR 3322.80
-
EUR 831.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
Cancer Antigen 125 Antigen (Human Adenocarcinoma) |
VAng-Cr3868-10kU |
Creative Biolabs |
10 kU |
EUR 505.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
Cancer Antigen 125 Antigen (Ascites Fluid) |
VAng-Cr3870-10kU |
Creative Biolabs |
10 kU |
EUR 1132.8 |
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE. |
Cancer Antigen CEA Antigen (Human Fluids) |
VAng-Wyb8644-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL. |
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx110007 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx121442 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx135924 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx113889 |
Abbexa |
|
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx013727 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx339194 |
Abbexa |
|
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
abx330307-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
abx430563-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
Ovarian Cancer-Related Tumor Marker CA125 (Muc16) Antibody |
abx432168-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
20-abx322829 |
Abbexa |
|
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
abx216976-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Human Cancer PrimaCell12: Ovarian Tumor Cells Growth Medium |
9-46035 |
CHI Scientific |
5 x 100 ml |
Ask for price |
Guinea Pig Ovarian cancer marker-CA125 ELISA Kit |
EGO0345 |
Abclonal |
96Tests |
EUR 625.2 |
ELISA kit for Human OCIAD2 (Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2) |
ELK6833 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), APC |
4-PAR870Hu01-APC |
Cloud-Clone |
-
EUR 441.60
-
EUR 4318.80
-
EUR 1191.60
-
EUR 566.40
-
EUR 274.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with APC. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), Biotinylated |
4-PAR870Hu01-Biotin |
Cloud-Clone |
-
EUR 393.60
-
EUR 3236.40
-
EUR 943.20
-
EUR 484.80
-
EUR 271.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with Biotin. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), Cy3 |
4-PAR870Hu01-Cy3 |
Cloud-Clone |
-
EUR 538.80
-
EUR 5708.40
-
EUR 1539.60
-
EUR 705.60
-
EUR 316.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with Cy3. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), FITC |
4-PAR870Hu01-FITC |
Cloud-Clone |
-
EUR 376.80
-
EUR 3478.80
-
EUR 976.80
-
EUR 476.40
-
EUR 243.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with FITC. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), HRP |
4-PAR870Hu01-HRP |
Cloud-Clone |
-
EUR 402.00
-
EUR 3762.00
-
EUR 1052.40
-
EUR 511.20
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with HRP. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), PE |
4-PAR870Hu01-PE |
Cloud-Clone |
-
EUR 376.80
-
EUR 3478.80
-
EUR 976.80
-
EUR 476.40
-
EUR 243.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with PE. |
Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%) |
VAng-Cr3869-25kU |
Creative Biolabs |
25 kU |
EUR 967.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186. |
Cancer Antigen 19-9 Antigen (Liver Carcinoma) |
VAng-Cr3873-10kU |
Creative Biolabs |
10 kU |
EUR 472.8 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Cancer Antigen AFP Antigen (Human Cord Blood) |
VAng-Wyb8624-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL. |
Cancer Antigen AFP Antigen (Human hepatocellular carcinoma) |
VAng-Wyb8625-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL. |
Cancer Antigen CA-125 Antigen (Human Fluids) |
VAng-Wyb8639-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL. |
Cancer Antigen CA-125 Antigen (Human Adenocarcinoma) |
VAng-Wyb8642-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL. |
Cancer Antigen CEA Antigen (Human Metastatic Liver) |
VAng-Wyb8645-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL. |
Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Polyclonal Antibody (Human), APC-Cy7 |
4-PAR870Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 739.20
-
EUR 8493.60
-
EUR 2240.40
-
EUR 988.80
-
EUR 405.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2). This antibody is labeled with APC-Cy7. |
Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Antibody |
20-abx130652 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) Antibody |
20-abx130653 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Recombinant Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) |
4-RPC458Hu01 |
Cloud-Clone |
-
EUR 556.54
-
EUR 272.40
-
EUR 1756.99
-
EUR 665.66
-
EUR 1211.33
-
EUR 447.60
-
EUR 4212.48
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Cytosolic Ovarian Carcinoma Antigen 1 expressed in: E.coli |
Recombinant Cytosolic Ovarian Carcinoma Antigen 1 (COVA1) |
4-RPC458Mu01 |
Cloud-Clone |
-
EUR 578.04
-
EUR 278.40
-
EUR 1837.63
-
EUR 692.54
-
EUR 1265.09
-
EUR 462.00
-
EUR 4414.08
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Cytosolic Ovarian Carcinoma Antigen 1 expressed in: E.coli |
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (HRP) |
20-abx108512 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (Biotin) |
20-abx105674 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody (FITC) |
20-abx107091 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Human Cancer Tissue Preparation Buffer 12: Ovarian Tumor Cells |
9-80035 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Human Ovarian cancer- related protein 1, OCR1 ELISA KIT |
ELI-23518h |
Lifescience Market |
96 Tests |
EUR 988.8 |
CA125 (Cancer antigen) ELISA test |
11 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen) |
CA50 (Cancer antigen) ELISA test |
10 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen) |
CA153 (Cancer antigen) ELISA test |
12 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen) |
CA199 (Cancer antigen) ELISA test |
13 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen) |
Cancer Antigen CA19-9 Antibody |
abx020532-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Cancer Antigen CA19-9 Antibody |
abx020533-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
Cancer Antigen CA19-9 Antibody |
abx020534-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
Cancer Antigen CA19-9 Antibody |
abx020535-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
CEA (Cancer antigen) ELISA test |
9 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CEA (Cancer antigen) |
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
CA1991-N-10 |
Alpha Diagnostics |
10 KU |
EUR 634.8 |
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) |
VAng-Cr3875-25kU |
Creative Biolabs |
25 kU |
EUR 885.6 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Human Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
20-abx150879 |
Abbexa |
-
EUR 7970.40
-
EUR 4250.40
-
EUR 990.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Mouse Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
20-abx153745 |
Abbexa |
-
EUR 7970.40
-
EUR 4250.40
-
EUR 990.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx055432-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Pig Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx361716-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx363362-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Chicken Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx356893-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Monkey Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx359965-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human Ovarian Cancer-Related Tumor Marker CA125 (MUC16) CLIA Kit |
20-abx491157 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Mouse Ovarian Cancer-Related Tumor Marker CA125 (MUC16) CLIA Kit |
20-abx491158 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx252997-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Rat Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx256757-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Mouse Ovarian Cancer-Related Tumor Marker CA125 (MUC16) ELISA Kit |
abx255227-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Human Ovarian cancer- associated gene 2 protein, OVCA2 ELISA KIT |
ELI-35544h |
Lifescience Market |
96 Tests |
EUR 988.8 |
There was no important distinction between the cumulative recurrence incidence curves of the matched teams (P = .319).Laparoscopic surgical procedure for grossly EGC-mimicking AGC is perhaps secure by way of long-term survival final result. After confirming grossly EGC-mimicking AGC within the remaining pathology report, no further surgical procedure is perhaps required.